Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth (Status and Outlook) 2024-2030

Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth (Status and Outlook) 2024-2030

Long non-coding RNA is a type of gene that is longer than 200 nt and does not encode protein structural changes. Long non-coding RNA can interact with DNA and mRNA, regulate protein interaction expression, and regulate biological processes.

The global Long Non-coding RNA Sequencing (lncRNA-seq) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Long Non-coding RNA Sequencing (lncRNA-seq) Industry Forecast” looks at past sales and reviews total world Long Non-coding RNA Sequencing (lncRNA-seq) sales in 2022, providing a comprehensive analysis by region and market sector of projected Long Non-coding RNA Sequencing (lncRNA-seq) sales for 2023 through 2029. With Long Non-coding RNA Sequencing (lncRNA-seq) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long Non-coding RNA Sequencing (lncRNA-seq) industry.

This Insight Report provides a comprehensive analysis of the global Long Non-coding RNA Sequencing (lncRNA-seq) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long Non-coding RNA Sequencing (lncRNA-seq) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long Non-coding RNA Sequencing (lncRNA-seq) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long Non-coding RNA Sequencing (lncRNA-seq) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long Non-coding RNA Sequencing (lncRNA-seq).

United States market for Long Non-coding RNA Sequencing (lncRNA-seq) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Long Non-coding RNA Sequencing (lncRNA-seq) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Long Non-coding RNA Sequencing (lncRNA-seq) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Long Non-coding RNA Sequencing (lncRNA-seq) players cover Aksomics, Anshengda, BGI, Annuoyouda Gene Technology, LC Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Long Non-coding RNA Sequencing (lncRNA-seq) market by product type, application, key players and key regions and countries.

Segmentation by Type:

Equipment Supplies

Service

Segmentation by Application:

Developmental Biology

Oncology

Neuroscience

Other

This report also splits the market by region:

Americas
United States
Canada
Mexico
Brazil

APAC
China
Japan
Korea
Southeast Asia
India
Australia

Europe
Germany
France
UK
Italy
Russia

Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:

Equipment Supplies

Service

Segmentation by Application:

Developmental Biology

Oncology

Neuroscience

Other

This report also splits the market by region:

Americas
United States
Canada
Mexico
Brazil

APAC
China
Japan
Korea
Southeast Asia
India
Australia

Europe
Germany
France
UK
Italy
Russia

Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Aksomics

Anshengda

BGI

Annuoyouda Gene Technology

LC Sciences

Creative Biolabs

Eurofins Scientific

CD Genomics

Novogene

Beijing Compson Biotechnology Co., Ltd.

Biomark Biotechnology

BD

10x Genomics

Majorbio

QIAGEN

Roche

Please note: The report will take approximately 2 business days to prepare and deliver.